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ABSTRACT 
Airway dysfunction is prevalent in elite endurance athletes and when left untreated may 
impact upon both health and performance. There is now concern that the intensity of 
hyperpnoea necessitated by exercise at an elite level may be detrimental for an athlete’s 
respiratory health. This article addresses the evidence of causality in this context with the aim 
of specifically addressing whether airway dysfunction in elite athletes should be classified as 
an occupational lung disease. The approach used highlights a number of concerns and 
facilitates recommendations to ensure airway health is maintained and optimised in this 
population. We conclude that elite athletes should receive the same considerations for their 
airway health as others with potential and relevant occupational exposures.   
 
 
 
 
 
 
 
 
 
 
 
Key words: airway hyper-responsiveness, asthma, athlete, exercise-induced 
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INTRODUCTION 
Airway dysfunction is common in elite athletes with studies consistently demonstrating a 
prevalence of between 25-75%, depending on the group of athletes studied and the diagnostic 
criteria employed (1, 2). Thus whilst it is accepted that regular physical activity promotes 
wellbeing, there is legitimate concern that the frequent, prolonged periods of hyperpnoea, 
characteristic of certain high-level sports, may be detrimental to respiratory health (3). Indeed 
it has been argued that exercise hyperpnoea may actually cause ‘injury’ to the airways, 
promoting the development of airway dysfunction and respiratory symptoms (4). This 
concern is substantiated by evidence that transient airway hyper-responsiveness (AHR) is 
temporally associated with exposure to regular athletic training (5, 6). 
The negative consequences of exercise ‘injuring’ the airways are probably most acutely borne 
by elite endurance athletes, a group of individuals whose ‘occupation’ demands frequent 
episodes of prolonged hyperpnoea, often whilst exposed to potentially noxious stimuli (e.g. 
sport-specific environmental exposures). It has therefore been suggested that the development 
of airway dysfunction in this population could be considered akin to an occupational lung 
disease (7). While intense exposures to respiratory irritants such as chlorine, usually in the 
context of an accident, can induce an asthma-like disease (8), whether repeated workplace 
exposures at lower intensities have the same potential is far less clear (9).  
Applying a label of occupational disease in this setting raises implications for the care and 
treatment afforded to elite athletes. Indeed it is a key mandate of the International Olympic 
Committee – Medical Commission (IOC-MC) that no athlete is harmed by exposure to sport 
and that all care is taken to ensure their health is maintained.  
A number of articles have recently outlined the pathophysiological basis for airway injury in 
athletes (3, 10), however despite, or perhaps because of, the potential ramifications there has 
been no discussion as to whether airway dysfunction in elite athletes should be classified as 
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‘occupational lung disease’. Moreover there is no specific guidance in the relevant 
Respiratory Society statements (11-13).  
The aim of this review is therefore to specifically appraise whether the literature in this field 
substantiates classifying airway dysfunction in athletes as an occupational lung disease, with 
the purpose of improving clinical care and providing direction for future research. 
Publications in the peer-reviewed literature until May 2013 were reviewed using search terms 
such as ‘exercise-induced asthma or bronchoconstriction’, ‘airway hyper-responsiveness’, 
‘asthma’ in combination with ‘athletes’.  
APPROACH TO EVALUATING AN OCCUPATIONAL LUNG DISEASE  
The Occupational Safety and Health Administration describe occupational disease states as 
“any abnormal condition or disorder, other than one resulting from an occupational injury, 
caused by exposure to factors associated with employment”. More specifically, an 
occupational lung disease is a respiratory disorder ‘related to the inhalation of natural 
occurring or manmade agents of various chemical and physical compositions’ in the 
workplace (14). Occupational asthma specifically refers to new development of asthma in 
relation to a causative exposure within the workplace, whilst work-exacerbated asthma 
describes pre-existing or concurrent asthma that is worsened by agents within the workplace 
(15).  The development of occupational asthma spans a broad spectrum including IgE-
mediated allergen hypersensitivities, acute exposure to high concentration irritants and 
chronic exposure to low level agents (16). As the respective prognosis following exposure in 
these groups is poor, individuals with a confirmation of occupational asthma are advised to 
avoid further exposure following diagnosis of their disease to provide the greatest chance of 
recovery (16, 17).  
Throughout this review ‘airway dysfunction’ is used as a term to encompass the entities of 
exercise-induced bronchoconstriction (EIB), exercise-induced asthma (EIA), AHR and/or 
 5
asthma. However we recognise that the nomenclature in this area remains controversial (11) 
and therefore we have highlighted when findings apply specifically to EIB, AHR or asthma. 
Moreover, where relevant, we focus on differences between physiological phenomena and 
clinical disease characteristics.  
IS THERE AN INCREASED FREQUENCY OF AIRWAY DYSFUNCTION IN 
ATHLETES?  
There is now a plethora of data showing that the prevalence of airway dysfunction is 
significantly greater in athletes than in the general population (1). This higher prevalence is 
observed predominately in endurance athletes (i.e. those performing sustained intense 
exercise at sub-maximal level), most notably those participating in pool-based or winter 
sports (3), with a reported prevalence of up to 70% and 50% respectively (18-23). However, 
and of concern, it also appears that the prevalence of airway dysfunction is high in athletes 
undertaking sports that have mass participation (e.g. football and rugby) (24, 25). 
There is strong evidence for an interaction between the duration and characteristics of 
ventilatory demand in a given sport and the environmental irritant load, in leading to the 
development of airway dysfunction. In this respect, there is evidence to suggest that athletes 
who undertake endurance training have a greater prevalence of airway dysfunction (26). For 
example, the prevalence of EIB in cross-country skiers is typically four-fold greater than ski-
jump orientated athletes (3); both groups compete in winter conditions but there is a marked 
difference in their total ventilatory load (26). A similar relationship is evident in pool-based 
sports, in which at least >17% of Olympic swimmers are reported to have airway dysfunction 
(26), while indoor competition divers have a prevalence of ~4% (IOC Independent Asthma 
Panel, 2002-2011) (3).  
As the ventilation rate during swimming determines the quantity of inhaled chlorine 
derivatives, elite swimmers training for many hours per week are potentially at a greater risk 
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of developing airway dysfunction (27). In addition, a high prevalence of airway dysfunction 
has been observed in synchronised swimmers (26) and this may relate to the prolonged 
periods of time spent in apnoea following the inhalation of contaminated air.  
This acknowledged, the development of respiratory symptoms in pool-based (non–athletic) 
workers (28) supports the theory that environmental exposure is important in the development 
of airway dysfunction in competitive swimmers. Dickinson et al. (29) reported that the 
prevalence of airway dysfunction in the British Olympic Team was 21.2% and 20.7% 
respectively at the 2000 and 2004 Olympic Games; with highest prevalence in endurance 
athletes exposed to potentially noxious environments (e.g. chlorine derivatives in swimmers  
and carbon monoxide in cyclists). In contrast, sports that are neither characterised by a 
sustained elevation in ventilatory requirement, nor performed in allergy or irritant-laden 
environments (e.g. badminton or weight lifting) had a prevalence of EIB similar to that in the 
general population (26, 29) .  
DOES EXERCISE INDUCE AIRWAY DYSFUNCTION?  
A number of prospective studies of elite athletes have set out to examine the temporal 
relationship between exercise and development of airway dysfunction (Table 1).  
A deterioration in the lung function of winter-sport athletes over the course of their careers 
has been anecdotally recognised for some time (30). However others have failed to find a 
similar relationship in summer sport athletes (31). 
This acknowledged, in the context of airway function, it is more logical to examine changes 
in bronchial hyper-reactivity rather than progressive changes in static lung function. 
Accordingly, Knöpfli et al. (5) prospectively assessed bronchial reactivity on three occasions 
over a two-year period in the Swiss national triathlon team. Participants (n=7) were free from 
respiratory disease at study entry but over the course of the study all developed evidence of 
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increased bronchial reactivity (defined as a propensity to reduced lung function following 
exercise challenge) and almost half developed EIB. Based on predictive modelling of changes 
in lung function over the study period, the authors proposed that all members of the group 
would develop EIB within five years of starting to compete. 
It is important to highlight that in some cases an athlete may have pre-existing asthma that is 
exacerbated by their ‘occupation’. Indeed, an explanation often cited to explain the high 
prevalence of airway dysfunction in swimmers relates to a selection bias; whereby individuals 
with asthma are encouraged to take up swimming under the assumption that a warm humid 
pool environment is less asthmogenic (32). 
There is conflicting data in this area with some authors reporting that the vast majority of 
swimmers  develop respiratory symptoms subsequent to commencing their swimming career 
(33), whilst others report evidence of equal rates of childhood asthma in both pool and non-
pool based athletes (22). 
IS THERE AN EXPOSURE-RESPONSE RELATIONSHIP?  
In this context a ‘biological gradient’ can be evaluated by examining exposure time in a sport 
or cumulative hours training and how these modify the risk of airway dysfunction. Heir and 
Larson (34) reported that airway sensitivity to methacholine in cross-country skiers correlated 
negatively with changes in the volume of exercise performed. In addition, Stensrud et al. (35) 
observed increased AHR to methacholine in elite athletes with increasing age and training 
volume.  
Bougault et al. (20) and Bonsignore et al. (36) each reported a correlation between sputum 
neutrophilia and training load. In young competitive rowers the cellularity of induced sputum 
obtained shortly after ‘all-out’ tests correlates directly with minute ventilation during the bout 
(37).  
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More recently Pedersen and colleagues (38) reported that although adolescent swimmers do 
not have evidence of airway damage following the first few years of training, they develop 
respiratory symptoms, airway inflammation and AHR over the course of their careers.  
Overall, these studies support the notion that AHR and airway inflammation are heightened in 
some athletes exposed to repeated bouts of heavy endurance training performed in noxious 
environments.  
IS THE ASSOCIATION BIOLOGICALLY PLAUSIBLE?  
Plausibility related to exercise hyperpnoea  
Elite-level athletes often train up to three times a day at an intensity requiring ventilation 
levels to rise to 20-30 times those at rest (i.e. from 5 L/min to over 150 L/min). Ventilation 
rates in excess of 30 L/min result in a shift in breathing pattern from almost exclusive nasal 
airflow to combined oral and nasal airflow (39). As a result the lower airways are exposed to 
a greater quantity of unconditioned air and potential deposition of airborne allergens and other 
inhaled particles (e.g. pollutants).  
It is thought that exercise hyperpnoea precipitates EIB by inducing osmotic changes at the 
distal airway surface (40). This precipitates inflammatory mediator release and cellular ion 
shifts which ultimately results in airway smooth muscle contraction.  
Recent findings indicate that acute exercise hyperpnoea transiently disrupts the airway 
epithelium in both healthy and asthmatic athletes (41). In the chronic setting, repeated, 
prolonged periods of exercise hyperpnoea are associated with the development of airway 
change that is analogous to the pathological pattern seen in response to injury or insult; 
indicated by an increase in endobronchial debris, pro-inflammatory cells, cellular 
inflammatory mediators and airway remodelling (42, 43).  
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In a canine model, Freed and colleagues (44) demonstrated that a model mimicking exercise 
hyperpnoea, with insufflation of dry air, resulted in airway epithelial cell damage. In addition, 
repeated exposure to dry air hyperpnoea results in eosinophilic airway inflammation (45).  
Moreover, repeated airway cooling and desiccation through peripheral airway hyperpnoea, 
performed in dogs, resulted in airway inflammation and remodelling; supporting the 
hypothesis that asthma-like symptoms in elite winter sport athletes may be the result of 
repeated hyperpnoea with dry cold air (46). The inhalation of warm moist air has been 
recently identified to limit this airway epithelial cell perturbation and injury (41).  
In humans, the association between exercise hyperpnoea and airway dysfunction has perhaps 
been most extensively evaluated in winter sport athletes (47). In this highly specialised 
population, where athletes train and compete in sub-zero temperatures for several hours daily, 
cross-sectional studies have indicated a high prevalence of both respiratory symptoms and 
airway dysfunction (47). Moreover, endobronchial samples taken from elite cross-country 
skiers demonstrate increased epithelial basement membrane thickness and deposition of 
tenascin supporting the presence of chronic airway remodelling (42). Other studies reveal an 
increased presence of airway pro-inflammatory mediators (e.g. tumour necrosis factor-alpha) 
and airway neutrophilia in this population of athletes (19).  
Elite winter sport athletes, exposed to extreme cold and thus ‘noxious’ conditions, are not 
necessarily representative of the general elite athletic population. This acknowledged, a 
similar if somewhat less exaggerated pattern of chronic airway pathology is apparent in non-
winter sport athletes, including rowers (37) and swimmers (6, 48). In these athletes, studies 
also reveal evidence of epithelial damage and shedding after both acute and repeated exercise 
bouts (37, 49).  
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Others have reported increased serum and urine biomarker signals of active airway injury-
repair cycling, e.g. Clara cell protein – CC16, following dry air hyperpnoea (50). Importantly, 
changes in CC16 levels are attenuated with inhaled warm humid air, suggesting that dry air 
hyperpnoea in humans directly insults the airway. This insult may be transient and it is 
important to note that many of the pro-inflammatory changes apparent within the airway 
lumen following hyperpnoea are resolved over a short period (<24 hours) (50). 
Variable degrees of both neutrophilic and eosinophilic airway inflammation have been 
identified in summer sports athletes (51). The process driving cellular infiltration into the 
airway lumen in the context of exercise is complex (40, 44); it has been proposed that airway 
eosinophilia may relate to certain environmental exposures (e.g. indoor swimming pool 
toxins) (52). This supposition was supported by recent work revealing eosinophilia in the 
bronchial biopsies of swimmers (48). 
A further possible mechanism linking airway dysfunction and exercise hyperpnoea relates to 
the consequence of exercise hyperpnoea causing mechanical stress (53). Although somewhat 
controversial, repeated episodes of bronchoconstriction are now recognised to promote the 
development of structural changes within the airway wall and predispose to 
bronchoconstriction (54, 55) . In addition, airway shear stress may also promote release of 
chemo-attractants promoting a pro-inflammatory milieu (56).  
Despite this, it is important to acknowledge that murine studies have failed to demonstrate the 
development of airway injury or dysfunction in response to exercise training (57, 58). 
Moreover, in contrast to elite athletes, a reduction in airway reactivity has been observed in 
non-elite runners following a prolonged bout of exercise (59).  In addition, whilst an 
accelerated decline in FEV1 has been observed in occupational asthmatics, following repeated 
exposure to the causative agent (60), the long-term implications of structural airway 
remodelling on lung function (i.e. FEV1) in athletes has yet to be established. 
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Plausibility related to training environment  
A number of environmental pollutants or irritants have been implicated in the development 
and progression of airway dysfunction in elite athletes (21) (Table 2). A comprehensive 
review of the literature in this area is beyond the scope of this article but it is worth 
highlighting the evidence in two groups of well-studied athletes with a high prevalence of 
airway dysfunction (20, 61), namely swimmers and ice-arena athletes.  
Elite level swimmers may train up to 30 hours per week (49), inhaling air from just above the 
water surface where the mean chlorine concentration can be 0.4 mg/m3. Although below the 
threshold limited value of 1.45 mg/m3, this value could be reached and even exceeded when 
considering the total amount of chlorine that a swimmer inhales during a training session (62).  
Chlorine derivatives, used to disinfect swimming pools, interact with other chemicals in the 
water to form chloramines. Ambient chloramine levels have been linked with the 
development of upper respiratory symptoms and atopy in lifeguards and swimming pool 
workers (28). The mechanisms underlying the association between airway dysfunction and 
chloramine exposure remain unclear but it is recognised that chloramine exposure induces 
structural change in the airway epithelium and is associated with rapid increases in circulating 
proteins indicative of altered lung permeability (63). This is relevant for elite swimmers, who 
over a two-hour training session may be exposed to chlorine levels that exceed the 
recommended levels for a pool worker during an eight-hour exposure and over the course of a 
week will be exposed to 100 times more chlorine compounds than a recreational swimmer 
(64).  
Winter sport athletes (e.g. ice hockey players) can be subjected to high levels of pollutants 
emitted from internal combustion fossil-fuelled ice resurfacing machines such as carbon 
monoxide, nitrogen dioxide, sulphur dioxide and particulate matter (PM) (65). In particular, 
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ultra-fine particles (<0.1 µm) (PM0.1) have been identified as an important stimulus driving 
airway dysfunction (23, 66). The exact mechanism by which PM0.1 exposure induces airway 
dysfunction remains to be fully determined; however, systemic oxidative stress as a result of a 
release of inflammatory mediators from airway cells entering the circulatory system may be 
implicated (66).  
Plausibility related to allergen exposure 
Outdoor endurance athletes can be exposed to a very heavy aeroallergen load in the spring 
and summer seasons with the change in pattern of ventilation necessitated by hyperpnoea (to 
predominately mouth breathing) diminishing the nasal filtering of pollen particles. Moreover, 
exposures to common aeroallergens in indoor training arenas often exceed the threshold for 
sensitisation (67).  
In addition, a high proportion of young athletes are atopic in comparison to the general 
population (61, 68) with over 80% of allergic athletes poly-sensitised (69). One study 
reported that the risk of an athlete developing asthma was strongly associated with atopic 
disposition (70); the relative risk of developing asthma increasing ~25 fold in atopic speed 
and power athletes and ~75 fold in atopic endurance athletes in comparison to controls (71). 
Moreover, the likelihood of an athlete having increased bronchial responsiveness increases in 
relation to the number of positive skin responses to aeroallergen (72).  
It is possible that prolonged repeated exposure to pollen in sensitised athletes may induce 
mild persistent bronchial inflammation sensitising airway mast cells (73). In addition, 
epithelial damage mediated by exogenous factors such as allergen exposure has been 
postulated to be a key mechanism resulting in airway remodelling in asthmatics (74).  
Finally, it has been proposed that circulating levels of IgE in atopic athletes may result in the 
airway smooth muscle becoming ‘passively sensitised’ through transient yet repeated 
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exposure to bulk plasma (40). This sensitisation may alter contractile properties of the airway 
smooth muscle, resulting in a heightened sensitivity to inflammatory mediators (4, 40).   
DOES REDUCING EXERCISE OR RELATED EXPOSURES IMPROVE AIRWAY 
DYSFUNCTION?  
Helenius et al. (33) undertook a comprehensive five-year prospective evaluation of the effect 
of discontinuing high level exercise on airway inflammation, bronchial responsiveness and 
asthma in highly trained elite swimmers from the Finnish national team. In swimmers who 
stopped high-level training there was a reduction in eosinophilic airway inflammation and an 
attenuation or disappearance of AHR. In contrast, in the control group who continued 
intensive training on a regular basis, there was no such change.  
The findings are supported by those from a further study of elite level swimmers indicating 
that alterations in airway inflammation and AHR over a one-year period related to training 
load (6). More specifically, training load contributed to the development of AHR and the 
latter was reversed in the majority of athletes following a two-week recovery period.  
It would be reasonable to assume that reducing exposure to noxious agents would offer 
protection and result in a similar improvement in lung function. Devices such as face masks 
and heat and moisture exchange (HME) devices have been identified as novel strategies to 
increase the water content of inspired air - thereby reducing the rate of water loss from the 
airway. Furthermore, they possess the potential to increase inspired air temperature from -
10°C to at least 19°C, thus reducing the potential for airway injury (3). Such devices have 
been reported to block a cold exercise-induced decline in lung function at least as effectively 
as pre-treatment with salbutamol (75). 
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SUMMARY – SHOULD AIRWAY DYSFUNCTION IN ATHLETES BE CLASSIFIED 
AS AN OCCUPATIONAL LUNG DISEASE?  
Airway dysfunction has now been consistently reported in athletes training and competing 
across a range of both summer and winter endurance sports. Whilst we acknowledge that 
further work is required, the current best available evidence suggests the explanation for this 
association lies in the provocative nature of repeated exercise hyperpnoea performed in 
irritant laden environments.  
Injury or disease? 
To date much of the work evaluating elite athletes has examined surrogate markers of airway 
disease (i.e. presence of airway inflammatory change and/or hyper-reactivity) for which there 
may be a poor relationship with symptom burden. This has important implications for the 
classification of an athlete’s condition as an occupational ‘disease’. The latter can be defined 
as an ‘abnormal condition that affects the body of an organism’ (76), however it is generally 
accepted to describe a condition with specific symptoms and signs (77); with ‘injury’ being 
specifically excluded.  
In this respect, whilst there is an evolving literature indicating that pathophysiological airway 
change is more prevalent in elite level athletes (3, 43), there currently remains a paucity of 
detail relating this to manifestations classically associated with airway disease (e.g. 
exacerbations). Moreover, there is no current evidence to suggest long-term morbidity or 
mortality arising from the development of airway dysfunction in athletes (78).  
Implications for athletes 
The re-classification of airway dysfunction as an occupational lung disease would have a 
number of important implications. Firstly we speculate it is likely that few affected athletes 
would wish to stop performing their sport prematurely even if they were advised that this 
would probably lead to an improvement in their airway function. 
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Secondly, classifying airway dysfunction in athletes as an occupational disease would have 
implications if an athlete is considered ‘employed’. Specifically it raises considerations for 
insurance, remuneration and potentially dictates a requirement for sporting bodies and 
organisations to cover litigation arising from an athlete developing airway dysfunction. The 
‘employment’ status of elite athletes varies according to the sport and level of participation of 
an individual; premiership level professional footballers for example are often employed by 
their club whilst elite track athletes are usually supported by a grant but not officially 
‘employed’. By extension, it is also potentially relevant to consider occupations in which 
individuals (such as those in certain military roles) are required to exercise to a similar extent 
to endurance athletes.  
Thirdly, it raises issues for the way in which the airway health of athletes is monitored. In 
order to prevent airway dysfunction developing in elite athletes it first needs to be accurately 
detected. The screening of athletes for underlying disease has precedent in the field of 
cardiology. In some European countries, any individual wishing to compete in an official 
organised sporting event is required by law to undergo an annual electrocardiogram exercise 
test. Identification of an underlying cardiac abnormality results in immediate disqualification 
from participation. Although proponents of this approach point to a fall in cardiac-related 
deaths during exercise as a sign of its success (79), the relative merits of this process have 
been debated and some authors have argued that the cost implications preclude the 
introduction of a widespread cardiac screening programme (80, 81). Similar considerations 
need to be taken into account prior to the introduction of screening athletes for airway 
dysfunction.  
We have previously argued (2) that population screening of athletes for airway dysfunction is 
not substantiated when appraised against the WHO screening criteria; there remains too little 
clarity over diagnostic methodology and the natural course of the disease to support this 
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recommendation. Moreover, in any widespread screening programme the cost of 
implementation needs to be considered prior to initiation. Despite this, medical surveillance 
however is commonplace in certain high-risk occupations (e.g. air-force pilots and 
firefighters) and it may be that a similar programme would be appropriate in certain high-risk 
athletic groups, e.g. competitive swimmers.  
Protecting airway health in athletes 
Strategies aimed at a reduction in the factors driving airway dysfunction in athletes are 
paramount (Table 2). Both pharmacological and non-pharmacological strategies are likely to 
be relevant (3) and further research in this area is urgently needed. Beta-2 agonists are the 
most commonly used medication to treat EIB in athletes, yet although disputed, evidence of 
chronic, frequent use of beta-2 agonists has been reported to be associated with tachyphylaxis 
(82).  More specifically, evidence exists to suggest excessive use of short-acting 
bronchodilators result in adverse changes in lung function when inhaled corticosteroid (ICS) 
therapy is neglected (83).   Inhaled corticosteroids (ICS) administered on a daily basis have 
been identified to reduce the severity of EIB (84) and are considered the most effective anti-
inflammatory agent for EIB management (85). While the work of Sue-Chu and colleagues 
provides the only longitudinal data available in relation to daily treatment with ICS, indicating 
no beneficial effect on AHR to methacholine provocation (86), a wide body of literature is in 
opposition to these findings. Recent recommendations suggest patients who continue to 
experience symptoms despite frequent use of short-acting bronchodilators or administration 
before exercise to initiate daily ICS therapy (13). Likewise, while dietary modification (e.g. 
fish oil supplementation) may attenuate EIB (87) there are no data yet to support a long-term 
beneficial impact on airway integrity in athletes.  
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Methodological considerations / Focus for future research 
The structure of this review has been largely narrative given the brevity of literature examined 
and heterogeneous nature of the issues covered, i.e. the article draws together diverse 
manuscripts ranging from an examination of the effectiveness of screening to papers 
evaluating the biological evidence in support of airway injury in athletes.  
This approach limits the ability to systematically appraise the strength of the literature in this 
field. However as high quality data in this field continues to accumulate then it will be 
desirable to perform a formal systematic appraisal of the literature evaluating the key 
components of causality in the context of the relative strength of the data available (i.e. is the 
association biologically plausible). Until this time, readers are referred to up to date guideline 
documents by Parsons et al. that have employed a systematic and objectively graded process 
of manuscript appraisal (13). 
A further methodological consideration concerns the paucity of longitudinal studies in the 
field. Further prospective studies are required to truly evaluate the causal relationship in the 
development of airway dysfunction in athletes. As discussed previously, further research is 
also required to describe and distinguish the features of injury versus disease. This is central 
to permit focus on interventions that may protect athletes from developing airway 
dysfunction.  
Finally, the impact of undetected airway dysfunction on athletic performance is yet to be 
established. This should be a key focus for future research given that the ability to compete 
optimally is essential to an athlete’s ‘occupation’.   
Conclusion 
The available literature indicates that participation in high intensity exercise in certain 
environmental situations is implicated in the development of airway pathophysiology. Thus, 
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whilst the benefit of regular physical activity for health and well-being is widely recognised, 
there is legitimate concern that the intensity of hyperpnoea necessitated by elite level exercise 
may be detrimental for respiratory health. It remains to be determined how the development 
of airway dysfunction translates into classic ‘disease’ manifestations and further work is 
needed in this area. In the meantime it is our opinion that the evidence is currently sufficient 
to afford elite athletes the same considerations for their airway health as other individuals 
with potential and relevant occupational exposures.  
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TABLE FOOTNOTES  
Table 1. Longitudinal studies evaluating airway function in athletes.  
Definition of abbreviations: AHR, airway hyper-responsiveness; PM0.1, particulate matter 
(ultra-fine particles).  
 
Table 2. Sport-specific environmental exposures and their role and potential prevention. 
Definition of abbreviations: NOX, Nitrogen oxide; PM0.1, particulate matter (ultra-fine 
particles); AHR, airway hyper-responsiveness. 
 
 20
Table 1. 
First Author  Design /  Follow-up Cohort Outcome measures Key findings  
Helenius (33) 5 year prospective  
Elite competitive swimmers (n 
= 42)  
Histamine challenge 
Sputum cytology 
Eosinophilic airway inflammation increased in 
swimmers who continued to train regularly. 
AHR attenuated in athletes who stopped training. 
Verges (30) 10 year prospective  
Elite cross country skiers (n = 
3) Methacholine challenge 
Airflow limitation present in all case studies 
following 9-12 years.  
Rundell (23) 4 year prospective  
Female ice-hockey players (n = 
14) 
Nordic skiers (n = 9) (control) 
Exercise challenge 
Controls showed no decline in lung function over 
4 years, however ice hockey player’s lung 
function deteriorated over the same time period. 
PM0.1 related to airway function decay in ice rink 
athletes. 
Kippelen (31) 1 year prospective  
Cyclists (n = 6) and triathletes 
(n = 7) 
Physically inactive (<2 
hrs/week) (n = 6)  
Exercise challenge 
Symptom questionnaire 
No evidence of lung function deterioration in 
healthy Mediterranean endurance trained athletes. 
Knöpfli (5) 2 year prospective  
Swiss national triathlon team; 
healthy and non-asthmatic (n = 
7) 
Exercise challenge  
AHR present in 43% of athletes.  
Athletes developed AHR over a short follow-up 
period. 
Bougault (6) 1 year prospective  
Competitive swimmers (n = 19) 
training >10 hr/week  
Control group (n = 16) non- 
asthmatic; not involved in 
competitive sport and did not 
swim regularly 
Exhaled nitric oxide 
Eucapnic voluntary 
hyperpnoea 
Methacholine challenge 
Sputum cytology 
Training may contribute to the development of 
AHR in elite swimmers, but this appears 
reversible after 2 weeks training cessation. 
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Table 2. 
First Author  Potential irritant Key findings / authors study conclusions Preventative strategies to be considered 
Pool-based sport (e.g. swimming, water polo, triathlon)  
Bougault (6) 
Bougault (88) 
Helenius (33) 
Helenius (64) 
Carbonelle (89) 
Chlorine derivatives 
- sodium 
hypochlorite and 
chlorinated 
isocyanuric acids 
Trihalomethanes – 
chloroform 
Haloacetic acids - 
trichloroacetic acid 
Chloramines 
Chronic long-term and repeated exposure to chlorine 
compounds in swimming pools during training and 
competition implicated in the increased prevalence of 
bronchial hyper-responsiveness, airway inflammation 
and structural remodelling processes in swimmers. 
 
 Train in outdoor pools when possible to achieve 
optimum ambient ventilation. 
 Athletes without access to outdoor facilities 
should choose to train in well-ventilated indoor 
pools (i.e. a flow rate of fresh air of at least 60 
m3/h). Staff should monitor training environment. 
 Swimming pools should implement good sanitary 
practice, e.g. wearing a swim cap, removing 
cosmetics prior to entering the pool area. Athletes 
should be instructed to shower before entering 
the pool to reduce chloramine formation. 
 Use of non-chemical pools (e.g. Ozone) need 
further investigation however impractical and 
may increase infection.  
Winter sport    
Indoor (e.g. speed skating, ice hockey)   
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Rundell (23) 
Rundell (18) 
Lumme (61) 
Levy (65) 
Brauer and Spengler 
(90) 
 
Carbon monoxide 
Nitrogen dioxide 
Sulphur dioxide 
Diesel fuel 
Particulate matter 
Daily high ventilation rates with cold dry air and ice 
re-surfacing pollutants implicated in development of 
airway dysfunction. 
 
 Indoor air quality should be monitored, with 
particular attention regarding the levels of NOX 
and PM0.1. 
 Incorporate ‘fresh air’ recovery periods into 
training sessions. 
 Utilise electric-powered ice resurfaces to ensure 
acceptable air quality. 
 
Outdoor (e.g. cross-country skiing, biathlon)  
  
 
Sue-Chu (91) 
Verges (30) 
Karjalainen (42)  
Cold / dry air 
Environmental stress to the proximal and distal 
airway 
Results in the development of respiratory symptoms, 
airway inflammation, AHR, epithelial injury and 
structural remodelling. 
 Warm up prior to exercise. 
 Nasal breathing during low intensity training.  
 Face masks/heat and moisture exchange devices 
to reduce respiratory water and heat loss. 
 Athletes should adhere to the Federation 
Internationale de Ski’s medical 
recommendations. 
 Skiers performing their own ‘hot waxing’ should 
carry this out as quickly as possible in well-
ventilated conditions. 
Summer sport    
 
 23
Knöpfli (5) 
Helenius and Haahtela 
(49) 
Helenius (67) 
Helenius (70) 
Weiler (92) 
 
Humid / dry air 
Aeroallergens 
Aeroallergens (dog, cat and mite) identified within 
indoor arenas exceeding the threshold for allergic 
symptoms and/or sensitisation.  
 Ensure good ventilation of indoor facilities. 
 Warm up prior to exercise. 
 Incorporate ‘fresh air’ recovery periods into 
training sessions. 
   
Helenius and Haahtela 
(49) 
Helenius (70) 
Helenius (93) 
Helenius (72) 
Primary agents 
Carbon monoxide 
Carbon dioxide 
Sulphur dioxide 
Nitric oxide 
Aeroallergens 
Pollen 
Secondary agents 
Ozone  
Nitric acid 
Sulphuric acid 
Nitrate 
peroxyacetyl 
Inorganic 
compounds 
Exposure to high levels of environmental pollutants / 
irritants / allergens when combined with prolonged 
exercise hyperpnoea may provoke nose and throat 
infection, lung function deterioration including 
airway inflammation. 
 
 Warm-up prior to exercise. 
 Avoid areas of high pollution (PM levels above 
Environmental Protection authority levels). 
 Incorporate buffer zone away from traffics 
areas. 
 Monitor training environment and organise 
training time to minimise exposure – i.e. early 
morning. 
 Atopic athletes should assess pollen counts 
prior to training.  
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